Hormone Receptor Status and TN Stage Influence the Locoregional Benefit From Trastuzumab in Patients With HER 2–Positive Breast Cancer After Adjuvant Radiation Therapy

2014 ◽  
Vol 90 (1) ◽  
pp. S244-S245
Author(s):  
L. Cao ◽  
G. Cai ◽  
X. Yu ◽  
J. Ma ◽  
Z. Yang ◽  
...  
2010 ◽  
Vol 3 (3) ◽  
pp. 109-115 ◽  
Author(s):  
Henry L. Gómez ◽  
Carlos A. Castañeda ◽  
Carlos E. Vigil ◽  
Tatiana Vidaurre ◽  
Raúl G. Velarde ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document